| Spirig HealthCare AG - Azacitidin Stada 150 mg, Pulver zur Herstellung einer Injektionssuspension |
| 69238 | | 02 | | Azacitidin Stada 150 mg | | Pulver zur Herstellung einer Injektionssuspension | | L01BC07 | | Azacitidine | | 18.09.2023 | | |
|
| Composition |
| azacitidinum 150 mg, mannitolum, pro vitro. |
| Packungsbestandteile |
| Powder for injection suspension | | | | | | | | Active Agent | Dose |
|---|
| Azacitidine | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Azacitidine | 150 mg |
| | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 304.64 | 347.75 | A | SL | No |
|
